Skip to main content
. 2019 Apr 7;11(4):170. doi: 10.3390/pharmaceutics11040170

Figure 2.

Figure 2

The profile of concentration vs. time course of 5(6)-carboxyfluorescein (CF) in the plasma after an enteric administration with SLG-30, a gemini surfactant, or typical absorption enhancers including sodium glycocholate and sodium laurate by an in situ closed-loop method. The results are expressed as the mean ± S.E. (n = 3). Keys: (◯) Control, (▲) 0.5% (v/v) SLG-30, (●) 0.5% (w/v) sodium laurate, and (■) 1% (w/v) sodium glycocholate.